Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Liver Steatosis in Induced Hepatocytes From Carriers of Spinal Muscular Atrophy.

Muscle & nerve·2026
Same author

Predictive Analysis of Amyotrophic Lateral Sclerosis Progression and Mortality in a Clinic Cohort From Singapore.

Muscle & nerve·2025
Same author

Development and Evaluation of a Deep Learning-Based Pulmonary Hypertension Screening Algorithm Using a Digital Stethoscope.

Journal of the American Heart Association·2025
Same author

Caring for people living with ALS in Korea: challenges and possible paths forward.

Muscle & nerve·2024
Same author

Describing and characterising variability in ALS disease progression.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2023
Same author

Translating fatigability in spinal muscular atrophy to clinical trials and management.

Muscle & nerve·2023

相关实验视频

Updated: Jun 28, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

在多种患者数据库中用机器学习预测肌缩侧面硬化症的死亡率.

Ling Guo1, Ian Qian Xu2,3, Sonakshi Nag1,3

  • 1Institute for Infocomm Research (I2R), Agency for Science, Technology and Research (A*STAR), Singapore.

Muscle & nerve
|September 15, 2025
PubMed
概括

新模型使用任何临床访问预测肌缩侧面硬化症 (ALS) 死亡率,改善个性化护理和临床试验. 专蛋白和功能评分是关键的预测指标,在各种人群中得到验证.

关键词:
骨髓缩侧面硬化症 (ALS) 是一种多样化的外部验证.机器学习是机器学习.死亡率预测死亡率预测生存分析,生存分析.

更多相关视频

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K

相关实验视频

Last Updated: Jun 28, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K

科学领域:

  • 神经学 神经学
  • 生物统计学 生物统计学
  • 机器学习 机器学习

背景情况:

  • 预测肌缩侧面硬化症 (ALS) 的死亡率对于患者护理和临床试验设计至关重要.
  • 现有的模型有局限性,包括依赖早期数据,固定预测器关系和缺乏多样化的人口验证.

研究的目的:

  • 使用常规可用的临床数据开发和验证新的ALS死亡率预测模型.
  • 解决现有模型的局限性,将任何临床访问的数据纳入并对不同人群进行验证.

主要方法:

  • 在PRO-ACT数据库上训练了Royston-Parmar和eXtreme渐变增强模型,用于6个月和12个月的死亡率预测.
  • 在来自北美和新加坡ALS群体的独立数据集上验证的模型.
  • 评估特征的重要性和预测因素减少的影响.

主要成果:

  • 模型使用任何临床访问的数据实现了高预测性能 (AUC 0.768-0.865).
  • 专蛋白成为最重要的预测因子,其次是ALS功能评分尺度-修订斜率,四肢发病和其他临床变量.
  • 模型在独立的数据集上表现出强的表现,并在减少到七个关键预测指标时表现出强的表现.

结论:

  • 访问不可知的ALS死亡率预测模型被开发和验证在不同的人群中.
  • 确定了关键的预后特征,包括白蛋白和功能衰退.
  • 这些模型具有提高ALS患者护理和优化临床试验设计的潜力.